Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell Carcinoma

Clinical trial NCT07618793 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07618793
Sponsor: zhang yi
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Squamous Cell Carcinoma Carcinoma, Non-Small-Cell Lung (NSCLC)

Start date: 2026-06-01
Primary completion: 2027-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.